检索

标题
作者
Regulatory adaptive status in determining the effectiveness of lisinopril and fosinopril in patients with chronic heart failure with preserved left ventricular ejection fraction
Nedvetskaia S., Shubitidze I., Tregubov V., Pokrovskiy V.
A modern view of the place of b-blockers in the treatmentof cardiovascular disease: the choice of drug within a class is crucial
Ostroumova O., Fomina V., Smolyarchuk E.
Β-blockers: the lack of taskimplementation or the unwillingness of doctors in the russian federation to optimize the treatment?
Fomin I., Polyakov D.
Comparison of effectiveness of therapy with lisinopril and fosinopril in patients with diastolic chronic heart failure in the presence of hypertension disease
Merzlyakova S., Shubitidze I., Tregubov V., Pokrovskiy V.
Torasemid in the treatment of cardiovascular disease: the optimal use in conditions of comorbidity
Poteshkina N., Troshina A.
The place of Indapamide retard in the treatment of patients with left ventricular dysfunction and preserved systolic function in the presence of arterial hypertension
Tereshchenko S., Zhirov I.
Rationale for the use of sartans in patients with arterial hypertension
Stryuk R.
Pathogenetic treatment of chronic heart failure: the role of torasemide
Perepech N.
Priorities for choosing diuretics in the treatment of hypertensive disease: Evidence-based medicine, recommendation documents, and real clinical practice
Kompaniets O., Averin E.
Up-to date view on ƒ-blocker in treatment of arterial hypertension with heart failure
Gorokhovskaya G., Petina M., Nikolau E., Martynov A., Gorohovskaja G., Petina M., Nikolau E., Martynov A.
Once again about the clinical efficacy and safety of sartans
Minina Y., Khadzhieva B.
Protivoishemicheskoe, antiaritmicheskoe i sosudistoe deystvie ingibitora angiotenzinprevrashchayushchego fermenta zofenoprila v eksperimente
Shlyakhto E., Galagudza M., Syrenskiy A., Blokhin I., Konstantinov I., Nifontov E.
Stroke prevention in patients with atrial fibrillation and comorbidities
Ostroumova O., Voevodina N., Guseva T., Pavleeva E., Piksina G., Goloborodova I.
Beta-adrenergic blocking agent in cardiovascular disease: focus on metoprolol
Baryshnikov G., Stepanova I., Kudryavtseva N.
Blokatory beta-adrenergicheskikh retseptorov v lechenii arterial'noy gipertenzii u bol'nykh s khronicheskoy serdechnoy nedostatochnost'yu
Preobrazhenskiy D., Tarykina E., Sidorenko B., Ermakova T., Stetsenko T., Pataraya S.
Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Part I
Chazova I., Tyulyandin S., Vitsenia M., Ovchinnikov A., Poltavskaya M., Gilyarov M., Martynyuk T., Panchenko E., Fedotkina Y., Stenina M., Trophimova O., Ageev F.
Pharmacoepidemiological study of recommendations of diuretics for the treatment of hypertension in the outpatient setting
Ponomareva A., Kompaniets O., Linchak R., Nemirovskaya M., Strokan M., Babich A.
The application of ivabradine in the management of ischaemic heart disease
Gurevich M., Kuzmenko N.
Modern opportunities of monotherapy in patients with arterial hypertension associated with comorbid disorders
Gorokhovskaya G., Yun V.
Acute heart failure and microRNA
Nasonova S., Mindzaev D., Zhirov I., Tereshchenko S.
MicroRNA in the diagnosis of chronic heart failure: state of the problem and the results of a pilot study
Zhirov I., Kochetov A., Zaseeva A., Liang O., Skvortsov A., Abramov A., Gimadiev R., Masenko V., Tereshchenko S.
Angiotensin II receptor blockers in the treatment of arterial hypertension in patients with concomitant pathology: focus on candesartan
Trukhan D.
1 - 22 的 22 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语